122. Superficial siderosis Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 4 / Drugs : 8 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Deferiprone
Department of Neurology, Tokyo Medical and Dental University
2024 - JPRN-UMIN000021218 Japan
Sanjo Nobuo
2019 - JPRN-jRCTs031180438 -
DNA BIO-banking
University College, London
2020 - NCT04200664 United Kingdom
Hearing assessment
University College, London
2020 - NCT04200664 United Kingdom
Inosine
Superficial Siderosis Research Alliance Inc.
2023 - NCT04890808 -
IP6
Superficial Siderosis Research Alliance Inc.
2023 - NCT04890808 -
Olfactory (smell) function testing
University College, London
2020 - NCT04200664 United Kingdom
Quality OF life assessment
University College, London
2020 - NCT04200664 United Kingdom
Vestibular/balance assessment
University College, London
2020 - NCT04200664 United Kingdom
Department of Neurology, Tokyo Medical and Dental University
2024 - JPRN-UMIN000021218 Japan
Sanjo Nobuo
2019 - JPRN-jRCTs031180438 -
DNA BIO-banking
University College, London
2020 - NCT04200664 United Kingdom
Hearing assessment
University College, London
2020 - NCT04200664 United Kingdom
Inosine
Superficial Siderosis Research Alliance Inc.
2023 - NCT04890808 -
IP6
Superficial Siderosis Research Alliance Inc.
2023 - NCT04890808 -
Olfactory (smell) function testing
University College, London
2020 - NCT04200664 United Kingdom
Quality OF life assessment
University College, London
2020 - NCT04200664 United Kingdom
Vestibular/balance assessment
University College, London
2020 - NCT04200664 United Kingdom